已投公司

观看

排序

2016-09-01

DIH蝶和科技与Hocoma完成全球智能康复领域最大规模合并 携手共创全球康复新未来

2016-06-07

Arvinas Publishes First Peer-Reviewed, In Vivo Data from its Proprietary PROTAC Technology

2016-06-07

Adimab and Innovent Expand Partnership for the Discovery of Antibodies and Bispecifics

2016-06-06

Invitae announces the launch of CancerCHECK to guide and support community oncologists through the hereditary cancer genetic testing process

2016-06-06

ARMO BioSciences’ AM0010 Demonstrates Promising Clinical Data as an Immuno-oncology Monotherapy and in Combination with an Anti-PD-1 Checkpoint Inhibitor in Advanced Solid Tumors, Including Immune-Resistant Cancers

2016-06-06

Principia Biopharma Announces Presentation of Initial Clinical Data on PRN1371 at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

2016-06-06

Seres Therapeutics Announces Research Collaboration with Mayo Clinic to Identify Microbiome Therapeutics for Primary Sclerosing Cholangitis, Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases

2016-06-05

Adaptimmune Announces Data from Clinical Studies of NY-ESO-1 SPEAR™ T-Cells in Multiple Cancers at the 2016 Annual American Society of Clinical Oncology (ASCO) Meeting

2016-06-03

Crizotinib Demonstrates Clinical Benefit in Phase II Study of East Asian Patients with ROS1-Positive Non-Small Cell Lung Cancer

2016-06-03

Pieris Pharmaceuticals Announces $16.5 Million Private Placement

2016-06-02

Publication of the LOCATION clinical study results in the renowned scientific journal of the European Atherosclerosis Society (EAS)

2016-06-02

argenx announces efficacy and expanded safety data from Phase 1 trial of ARGX-111

2016-06-02

argenx successfully closes €30 million private placement

2016-05-31

Singulex Announces a $50 Million Investment by Grifols for a 20% Stake in the Company

2016-05-27

FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBC

2016-05-26

Symbiomix Therapeutics Announces Positive Results from Phase 3 Trial of SYM-1219 for Bacterial Vaginosis, and Pre-NDA Meeting with FDA Supportive of 2016 NDA Filing

2016-05-25

Good Start Genetics Announces Newest Launch of Next-Generation Embryo Screening Product

2016-05-25

Relypsa Submits Supplemental New Drug Application to FDA Requesting Label Changes for Veltassa Based on Phase 1 Drug-Drug Interaction Studies

2016-05-20

Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO™

2016-05-19

True North Therapeutics to Present Clinical Data in Patients with Cold Agglutinin Disease (CAD) for Lead Product Candidate TNT009

2016-05-19

TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients’ Neurological Outcomes in TAVR Procedures

2016-05-19

Selecta Biosciences Obtains Exclusive License to Proprietary Gene Therapy Vector from Massachusetts Eye and Ear

2016-05-17

Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

2016-05-17

SI-BONE, Inc. Announces Publication of Second Multicenter Randomized Controlled Trial of the iFuse Implant System vs. Conservative Care in European Spine Journal

2016-05-11

Intellia Therapeutics Announces Closing of Initial Public Offering

2016-05-11

Roka Bioscience Announces Extended On Board Stability for all Assays on the Atlas® System

2016-05-07

Dimension Therapeutics Announces Preclinical Data from Bayer-Partnered Hemophilia A Program at American Society for Gene and Cell Therapy (ASGCT) Annual Meeting

2016-05-04

Audentes Therapeutics and the University of Pennsylvania Announce Collaboration to Develop AAV Gene Therapy for Severe Liver Disease

2016-04-27

Adimab Announces Two New Partnerships and Commercial Licenses with Lilly, Kite and Jounce

2016-04-27

Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting

2016-04-25

Vifor Fresenius Medical Care Renal Pharma and Relypsa Announce Submission of Marketing Authorization Application Requesting European Approval of Veltassa® for the Treatment of Hyperkalemia

2016-04-22

Adaptimmune Announces SPEAR T-cells™ Brand for Proprietary Technology

2016-04-21

"Affimed Presents Data on EGFRwt and EGFRvIII-targeting NK- and T-Cell TandAbs at the AACR Annual Meeting 2016"

2016-04-21

"Affimed Presents Data on AFM13-mediated Innate/Adaptive Immune Crosstalk at the AACR Annual Meeting 2016"

2016-04-20

ARMO BioSciences Announces AM0010 Clinical Data to be Presented at the American Society of Clinical Oncology Annual Meeting in June 2016

2016-04-20

SI-BONE, Inc. Announces Publication of Two-Year Results From a Prospective Multicenter Clinical Trial Showing Long-Term Clinical Benefits from SI Joint Fusion with the iFuse Implant System

2016-04-20

argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target

2016-04-19

Corvus Pharmaceuticals Announces Results of Preclinical Studies Demonstrating Enhanced Immune Responses and Anti-Tumor Activity with CPI-444, an Investigational Immuno-Oncology Therapy

2016-04-19

Loxo Oncology Announces First Pediatric Response to LOXO-101

2016-04-18

Otonomy Announces Phase 3 Clinical Trial Plan for OTIPRIO™ in Otitis Externa Patients Based on Successful End-of-Phase 2 Review by FDA

2016-04-18

Treatment with ViewRay’s MRI-Guided Radiation Therapy Now Available on the U.S. East Coast

2016-04-18

Avedro Receives FDA Approval for Photrexa® Viscous, Photrexa® and the KXL® System for Corneal Cross-Linking

2016-04-18

"TigerText to Offer Secure Messaging Services to U.S. Cellular Customers "

2016-04-17

oxo Oncology TRK Inhibitor LOXO-101 Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers in AACR Phase 1 Update

2016-04-14

New Analyses of the Phase 3 POISE Trial of Ocaliva™ (Obeticholic Acid) for the Treatment of PBC Presented at EASL

2016-04-11

Nabriva Initiates Second Phase 3 Clinical Trial of Lefamulin (“LEAP 2”) in Patients with Community-Acquired Bacterial Pneumonia (CABP)

2016-04-11

Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics

2016-04-07

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva™ (obeticholic acid) for the Treatment of PBC

2016-04-07

Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver Cancer

2016-04-06

Good Start Genetics Appoints Chief Executive Officer

2016-04-06

Aeglea BioTherapeutics Announces Pricing of Initial Public Offering

2016-04-04

Cynapsus Therapeutics and MonoSol Rx Announce Global IP Licensing Agreement

2016-04-03

FDA grants orphan drug status to ganaxolone for pediatric female epilepsy

2016-03-30

U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma

2016-03-29

Invitae announces major expansion of its test menu for neurological, pediatric, and rare genetic conditions and introduces new panels for inherited metabolic disorders and newborn screening confirmation

2016-03-28

SONENDO® RECEIVES FDA 510(K) CLEARANCE FOR THE NEXT GENERATION OF THE GENTLEWAVE® SYSTEM

2016-03-24

First MRIdian System Installed in Europe at VU University Medical Center of Amsterdam

2016-03-23

Otonomy Initiates Patient Enrollment in Second Phase 3 Clinical Trial of OTO-104 in Ménière’s Disease

2016-03-22

Acutus Medical Completes $75 Million Series C Financing

2016-03-22

Corvus Announces Pricing of Initial Public Offering

2016-03-21

Blue Cross Blue Shield of Michigan Announces Positive Coverage Policy for iFuse Implant System® MIS SI Joint Fusion

2016-03-17

Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation for DTX301 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

2016-03-17

Pieris Pharmaceuticals Announces Presentation of In Vivo Preclinical Data for Its Lead Bispecific Immuno-Oncology Drug Candidate, PRS-343, at the 2016 Annual Meeting of the American Association for Cancer Research (AACR)

2016-03-14

Aeglea BioTherapeutics Announces FDA Acceptance of its Investigational New Drug Application for AEB1102 for the Treatment of Hematological Malignancies

2016-03-14

ProNAi Therapeutics Granted Orphan Drug Designation for PNT2258 for the Treatment of Diffuse Large B-Cell Lymphoma

2016-03-09

Intellia Founders Awarded Distinguished Alpert Prize

2016-03-03

Otonomy Initiates Phase 2 Clinical Trial of OTIPRIO™ in Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes

2016-03-02

Otonomy Announces Commercial Availability of OTIPRIO™

2016-02-29

Clementia Announces Last Patient Enrolled in Phase 2 trial of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva

2016-02-25

True North Therapeutics Receives Orphan Drug Designation in the European Union for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, including Cold Agglutinin Disease (CAD)

2016-02-17

argenx opens clinical trial sites in South Korea for ARGX-111 program

2016-02-12

SI-BONE, Inc. Announces Medicare Administrative Contractor National Government Services, Inc. Establishes Positive Coverage for MIS SI Joint Fusion Effective April 1st, 2016

2016-02-10

ARMO BioSciences Raises $50 Million Series C Financing

2016-02-09

Seres Therapeutics Announces Publication of Positive SER-109 Phase 1b/2 Study Results in The Journal of Infectious Diseases

2016-02-09

U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma

2016-02-08

Sientra® Announces Return of All Products to U.S. Market

2016-02-04

Cerapedics Announces Publication of Results from Pivotal IDE Clinical Trial of i-FACTOR™ Bone Graft in the Cervical Spine

2016-02-02

Adaptimmune and GSK expand Strategic Immunotherapy Collaboration

2016-02-02

argenx receives milestone payment in LEO Pharma collaboration

2016-02-01

GLAUKOS LAUNCHES NEW DIRECT SALES ORGANIZATION AND BEGINS COMMERCIALIZATION OF ISTENT INJECT® TRABECULAR MICRO-BYPASS STENT IN CANADA

2016-02-01

argenx receives milestone payment in LEO Pharma collaboration

2016-02-01

Aduro Biotech Receives $22.4 Million in Clinical Development Milestone Payments From Janssen

2016-02-01

"Good Start Genetics’ Cost Effectiveness Study Demonstrates Clinical Outcomes

2016-01-28

Catalent Biologics And Cerenis Therapeutics Announce Phase III Trial Of CER-001 In Europe And North America Leveraging GPEx® Cell Line Technology

2016-01-26

Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

2016-01-25

Relypsa Announces Results From Veltassa Drug-Drug Interaction Studies in Healthy Volunteers

2016-01-25

Affirmed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA (pembrolizumab) for Patients with Hodgkin Lymphoma

2016-01-20

INTERNATIONAL STUDY SHOWS 3-YEAR BENEFITS OF GLAUKOS ISTENT® TRABECULAR MICRO-BYPASS STENT IN COMBINATION WITH CATARACT SURGERY

2016-01-20

SI-BONE, Inc. Announces European Expansion with Formation of SI-BONE UK Ltd and Key Additions to Management Team

2016-01-19

ACORDA ANNOUNCES A RECOMMENDED CASH TENDER OFFER FOR ALL SHARES, ADSs AND OTHER EQUITY INSTRUMENTS IN BIOTIE

2016-01-19

argenx announces € 16 M investment by US funds advised by subsidiaries of Federated Investors

2016-01-15

Loxo Oncology Announces EMA Orphan Drug Designation Granted to LOXO-101 for Treatment of Soft Tissue Sarcoma

2016-01-14

Practice Fusion Accelerates Revenue Growth and Adds 5,000 New Active Practices in 2015

2016-01-12

Adimab Announces Technology Transfer Agreement with Merck

2016-01-12

Otonomy Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

2016-01-12

Tricida Announces FDA Acceptance of Investigational New Drug Application for Lead Candidate TRC101 and Hiring of Claire Lockey as Chief Development Officer and Edward J. Hejlek as General Counsel

2016-01-12

Intellia Therapeutics Launches New Division to Accelerate Ex Vivo Programs with CRISPR/CAS9

2016-01-11

Helix Expands Ecosystem for Consumer Genomics Through Two New Partnerships

2016-01-11

Seres Therapeutics Announces Strategic Collaboration with Nestlé Health Science for Microbiome-Based Clostridium Difficile and Inflammatory Bowel Disease Therapies in Markets Outside of North America

2016-01-11

Adimab Provides Update on Recent Partnerships and Milestones

2016-01-08

Invitae announces it met volume guidance by delivering nearly 19,000 billable tests in 2015 and sets volume guidance at 50,000-70,000 billable tests for 2016

2016-01-07

Adaptimmune Expands T-cell Engineering Expertise to Develop Affinity Enhanced T-cell Therapies for Autoimmune Indications

2016-01-07

Cynapsus and Michael J. Fox Foundation Collaborate on Pilot Use of Wearable Device and Data Science Approaches in Phase 3 Parkinson’s Clinical Study

2016-01-07

Alector Announces Closing of Series D Financing – Total Capital Raised in 2015 Exceeds $60M

2016-01-07

"Aeglea BioTherapeutics Announces FDA Acceptance of its

2016-01-07

Principia Biopharma Advances BTK Inhibitor Program in Autoimmune Disease and FGFR Inhibitor Program in Oncology

2016-01-07

Rhythm Receives Orphan Drug Designation for Setmelanotide for the Treatment of Prader-Willi Syndrome

2016-01-07

Rhythm Receives FDA Breakthrough Therapy Designation for Setmelanotide for Treatment of POMC Deficiency Obesity

2016-01-07

GLAUKOS WILL BEGIN PHASE II CLINICAL TRIAL FOR IDOSE™ TRAVOPROST INTRAOCULAR IMPLANT IN GLAUCOMA PATIENTS

2016-01-07

Dimension Therapeutics Announces Initiation of Phase 1/2 Study for DTX101 for the Treatment of Hemophilia B

2016-01-06

Sage Therapeutics Announces Pricing of Public Offering of Common Stock

2016-01-05

argenx announces initial results from a Phase 1 single ascending dose study of ARGX-113 in healthy volunteers

2016-01-05

Aduro Biotech Expands Patent Portfolio With Key Newly Issued Composition and Methods Patents

2015-12-23

Avedro Announces CE Mark Clearance for its Mosaic Advanced Cross‐Linking System and CEO Transition

2015-12-23

Selecta Biosciences Announces Dosing of First Patient in Phase 1b Clinical Trial for SEL-212

2015-12-22

Loxo Oncology Announces First Patient Enrolled in Phase 1 Trial of LOXO-101 in Pediatric Cancer Patients

2015-12-21

Relypsa Announces Veltassa™ is Now Available in the United States for the Treatment of Hyperkalemia

2015-12-21

Mirati Therapeutics Initiates Glesatinib (MGCD265) Phase 2 Trial In Non-Small Cell Lung Cancer (NSCLC)

2015-12-21

SI-BONE, Inc. Announces Medicare Administrative Contractor CGS Administrators, LLC Establishes Positive Coverage for MIS SI Joint Fusion Effective February 1st, 2016

2015-12-21

Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)

2015-12-21

Guardant Health And Mirati Therapeutics Enter Into Collaboration On Glesatinib (MGCD265) In Non Small Cell Lung Cancer (NSCLC) Trial

2015-12-21

Aduro Biotech Announces Initiation of Phase 1 Study of ADU-741 for the Treatment of Prostate Cancer

2015-12-18

ProNAi Therapeutics Added to NASDAQ Biotechnology Index

2015-12-17

FDA Extends PDUFA Date for Obeticholic Acid for the Treatment of PBC

2015-12-17

Mirati Therapeutics Doses First Patient In Expansion Cohorts Of MGCD516 Phase 1b Trial In Genetically Selected Patients

2015-12-17

"Cerenis Therapeutics admitted to the SRD (Defered Settlement Service) “Long-only”"

2015-12-17

Adaptimmune Announces Initiation of Study to Evaluate its New Affinity Enhanced T-Cell Therapy Targeting MAGE-A10 in Patients with NSCLC, the Most Common Form of Lung Cancer

2015-12-16

Aduro Biotech Receives Milestone Payment From Janssen for Acceptance of Investigational New Drug Application for ADU-741 in Prostate Cancer

2015-12-16

Marinus Pharmaceuticals Completes Patient Recruitment in Phase 3 Clinical Trial of Ganaxolone in Focal Onset Seizures

2015-12-15

Commercial Launch of the Long SpineSTAR® Ablation Instrument

2015-12-15

Otonomy Added to NASDAQ Biotechnology Index

2015-12-15

INTERNATIONAL STUDY DEMONSTRATES POTENTIAL FOR TITRATABLE TREATMENT WITH 1, 2 OR 3 GLAUKOS ISTENT® TRABECULAR MICRO-BYPASS STENTS IN OPEN-ANGLE GLAUCOMA PATIENTS

2015-12-14

Aduro Biotech Receives Orphan Drug Designation in the European Union for CRS-207 and GVAX Pancreas for the Treatment of Pancreatic Cancer

2015-12-14

Affimed Added to NASDAQ Biotech Index

2015-12-14

Seres Therapeutics Announces Initiation of a Phase 1b Clinical Trial of SER-287 in Mild-to-Moderate Ulcerative Colitis

2015-12-11

Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery

2015-12-10

Aduro Biotech Announces First Patient Dosed in Phase 1 Study of ADU-214 for the Treatment of Lung Cancer

2015-12-10

Cynapsus Announces Successful Completion of Bioavailability and Pharmacokinetic Study and Provides Update on European Clinical Plans

2015-12-09

Clementia Clinical Program: Clementia Natural History Study and Phase 2 Clinical Trial Enrollment Update

2015-12-08

Cynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson’s Disease and Related Disorders Meeting

2015-12-08

Pieris Pharmaceuticals Announces First Cancer Immunotherapy Collaboration

2015-12-08

Adimab Establishes Antibody Discovery Collaborations with MD Anderson and Memorial Sloan Kettering

2015-12-07

Pieris Pharmaceuticals Presents Clinical Data for Its Hepcidin Antagonist Program, PRS-080, at the 2015 American Society of Hematology (Ash) Annual Meeting

2015-12-07

Marinus Presents Additional Responder Analysis Data for Ganaxolone in Focal Onset Seizures at the American Epilepsy Society Annual Meeting

2015-12-07

True North Therapeutics Presents Data in Patients with Cold Agglutinin Disease (CAD) Supporting Patient Profiles for TNT009 Phase 1b Study

2015-12-06

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

2015-12-06

Affimed Presents Data Comparing T-cell- and NK-cell-engaging TandAbs AFM11 and AFM12 at AS

2015-12-04

argenx to host workshop and webcast announcing topline clinical TCL data and preclinical AML data from ARGX-110 program

2015-12-03

True North Therapeutics Announces $40 Million Series C Financing

2015-12-03

Targeting Protein Homeostasis Holds Potential to Treat Solid Tumors and Blood Cancers

2015-12-03

Arvinas Presents Data at the 2015 ASH Annual Meeting

2015-12-02

ORIC Pharmaceuticals Announces $53 Million Series B Financing to Support Discovery and Development of Novel Therapies for Treatment-Resistant Cancers

2015-12-02

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuardTM Delivery Catheters

2015-12-01

Adaptimmune and Universal Cells announce Collaboration to Develop Allogeneic T-Cell Therapies

2015-12-01

Otonomy Completes Enrollment in OTIPRIO(TM) Phase 2 Trial and Demonstrates Clinical Feasibility in Patients With Acute Otitis Externa

2015-11-30

Pieris Pharmaceuticals Achieves Payment Milestone in Sanofi Collaboration

2015-11-30

Intercept Pharmaceuticals Initiates Phase 1 Study of INT-767, a Dual FXR and TGR5 Agonist

2015-11-24

Aduro Biotech Confirms All Clinical Trials Continue Unaltered and as Planned

2015-11-24

Adaptimmune Initiates Phase I / II trial Evaluating its Affinity Enhanced T-Cell Therapy Targeting

2015-11-24

At 3 Years, Inspire Upper Airway Stimulation Therapy Shows Significant Sustained Reductions in Sleep Apnea Severity

2015-11-23

Aduro Biotech Receives Orphan Drug Designation in the European Union for CRS-207 for the Treatment of Mesothelioma

2015-11-23

Cerapedics: A PMA First Opens New Opportunities in Cervical Spine Osteobiologics

2015-11-23

Arsanis Initiates Phase 1 Study of Lead Product Candidate ASN100

2015-11-23

ObsEva Closes CHF 60 (USD 60) Million in Series B Financing

2015-11-20

ObsEva and Kissei Pharmaceutical Announce Global Agreement to Develop and Commercialize KLH-2109 for the Treatment of Endometriosis

2015-11-20

InspireMD Announces Positive Twelve Month Follow-Up CARENET Trial Data at VEITH Symposium 2015

2015-11-19

GLAUKOS SUBMITS IND APPLICATION TO FDA TO STUDY IDOSETM TRAVOPROST INTRAOCULAR IMPLANT IN GLAUCOMA PATIENTS

2015-11-19

Pieris Pharmaceuticals Collaborator Daiichi Sankyo Doses First Subject in a Phase 1 Clinical Study for Lead Partnered Anticalin Program

2015-11-18

Aduro Biotech Receives Milestone Payment From Janssen for Submission of Investigational New Drug Application for ADU-741 in Prostate Cancer

2015-11-18

Invitae announces expansion of hereditary cancer testing menu

2015-11-17

Aerpio Therapeutics Reports Positive Clinical Results from the Phase 2a Study of Lead Candidate, AKB-9778, in Diabetic Macular Edema (DME): The TIME-2 Trial

2015-11-17

Loxo Oncology Announces the Closing of Its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

2015-11-14

Intercept Presents New Data Analyses on Non-Invasive Liver Testing From FLINT Trial of Obeticholic Acid in Nonalcoholic Steatohepatitis at AASLD 2015

2015-11-14

Intercept Presents New PBC Data at AASLD 2015

2015-11-12

Practice Fusion Announces Appointment of Tom Langan as Permanent Chief Executive Officer

2015-11-12

Avedro Completes New $32 Million Round of Financing

2015-11-12

US Patent Awarded to Singulex for Expanded Use of Biomarkers Troponin I and T to Detect Cardiac Health Status with Single-Molecule Methods

2015-11-11

Loxo Oncology Prices Follow-On Offering of Common Stock

2015-11-11

TigerText Closes on $50 Million in Financing to Accelerate Growth; Launches TigerText Anywhere Initiative

2015-11-09

Clementia Phase 2 Clinical Trial Site in London, UK Now Enrolling Children

2015-11-09

SI-BONE, Inc.® Announces iFuse Implant System® Receives Indication Cleared by the FDA that Includes Improved Pain, Patient Function and Quality of Life at 12-Months

2015-11-06

Rhythm Presents Positive Data from Phase 1b Study of Setmelanotide for the Treatment of Genetic Obesity

2015-11-05

Pieris Pharmaceuticals Announces Presentation of Clinical Data for Its Hepcidin Antagonist Program, PRS-080, at the 2015 American Society of Hematology (ASH) Annual Meeting

2015-11-05

Adaptimmune Announces Data from Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of SITC

2015-11-03

Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery

2015-11-02

Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.

2015-10-30

ARMO BioSciences Presents Positive Phase 1 Trial Results of AM0010 at Upcoming Medical Conferences

2015-10-29

ProNAi Initiates 'Brighton' Phase II Trial of PNT2258 in Patients with Richter's Transformation

2015-10-29

Aduro Biotech Receives Milestone Payment From Janssen for Acceptance of Investigational New Drug Application for ADU-214 in Lung Cancer

2015-10-28

Igenica Biotherapeutics Enters Into a Strategic Oncology Research Agreement with MedImmune

2015-10-28

Aduro Biotech and Protein Potential Present Data Demonstrating Novel Vaccine Offers 100% Protection in Malarial Model

2015-10-26

"Aeglea BioTherapeutics Doses First Patient in Phase 1 Study of AEB1102 for Treatment of Solid Tumors

2015-10-26

Loxo Oncology Announces Broad Pipeline Update at AACR-NCI-EORTC, Including New LOXO-101 Phase 1 Data

2015-10-26

Corvus Pharmaceuticals Enters Clinical Trial Collaboration Agreement

2015-10-23

Igenica Biotherapeutics to Present New Data on Proprietary SNAP Antibody Drug Conjugate Technology at Upcoming World ADC Summit

2015-10-22

arGEN-X Completes First Dosing of ARGX-113 for Severe Autoimmune Disorders

2015-10-21

Arvinas Secures $41.6M Series B Financing – Appoints New Board Members

2015-10-21

Dimension Therapeutics Announces Pricing of Initial Public Offering

2015-10-21

RELYPSA ANNOUNCES FDA APPROVAL OF VELTASSA(TM) (PATIROMER) FOR ORAL SUSPENSION FOR THE TREATMENT OF HYPERKALEMIA

2015-10-18

ViewRay® Receives Regulatory Approval to Sell MRI-Guided Radiation Therapy System in Korea

2015-10-15

Open Monoclonal Technology and ARMO BioSciences Announce Anti-PD1 Antibody and OmniAbTM Platform License Agreement

2015-10-14

Loxo Oncology Announces First Patient Enrolled in LOXO-101 Phase 2 Basket Trial in Patients With Solid Tumors Harboring TRK Fusions

2015-10-13

Audentes Therapeutics Raises $65 Million In Series C Financing

2015-10-13

Good Start Genetics Establishes National Relationship with UnitedHealthcare

2015-10-13

European Journal of Heart Failure Publishes Pre-Specified Sub-Group Analysis of Heart Failure Patients With Hyperkalemia From Phase 3 Trial of Patiromer FOS

2015-10-13

ViewRay® Receives 2015 Frost & Sullivan Technology Innovation Leadership Award

2015-10-09

Aerpio Therapeutics to Present TIME-2 Phase 2a Study of AKB-9778 in Diabetic Macular Edema Data at 2015 American Academy of Ophthalmology Annual Meeting Retina Subspecialty Day

2015-10-08

Clementia Clinical Program Update: Clementia Phase 2 Clinical Trial Site in Paris, France Now Enrolling Children

2015-10-08

Aduro Biotech Receives Milestone Payment From Janssen for Submission of Investigational New Drug Application for ADU-214 in Lung Cancer

2015-10-07

Invitae expands test menu to include hundreds of new genes, dozens of new test panels for cancer, cardiology, neuromuscular, pediatrics, and rare disorders

2015-10-06

Acutus Medical’s AcQMap™ High Resolution Imaging and Mapping System Provides High Resolution Cardiac Mapping Combined with Exceptional Accuracy in Ultrasound Chamber Reconstruction in Patients with Atrial Fibrillation

2015-10-06

SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217

2015-10-05

Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311

2015-10-01

Arvinas Inks Strategic License Agreement with Genentech

2015-09-30

FierceBiotech’s 2015 Fierce 15 – Alector

2015-09-30

FierceBiotech names Arvinas as one of its “Fierce 15” Biotech Companies of 2015

2015-09-30

FierceBiotech names Intellia Therapeutics as one of its “Fierce 15” Biotech Companies of 2015

2015-09-30

Nabriva Therapeutics Announces Exercise of Over-Allotment Option

2015-09-30

Positive Data Presented on Pieris Pharmaceuticals' Inhaled Asthma Program at ERS and Company Strengthens Management Team

2015-09-29

Good Start Genetics Announces EmbryVu

2015-09-28

Mirati Therapeutics Presents Interim Clinical Data From Ongoing MGCD516 Phase 1 Dose Escalation Study In Patients With Advanced Solid Tumors

2015-09-28

Palovarotene Phase 2 Study Milestone

2015-09-28

Intercept Pharmaceuticals Announces Initiation of REGENERATE Trial for Obeticholic Acid in NASH Patients With Advanced Liver Fibrosis

2015-09-26

Aduro Biotech Announces Phase 1b Mesothelioma Trial Featured in Spotlight Poster at ESMO/ECC

2015-09-24

FDA Office of Orphan Products Development Awards Rhythm $1 Million Grant to Support Phase 2 Study of Setmelanotide in Prader-Willi Syndrome

2015-09-24

Otonomy to Present Results for AuriPro(TM) Phase 3 and OTO-104 Phase 2b Clinical Trials at 2015 AAO-HNSF Annual Meeting

2015-09-24

Aduro Biotech Enters Into Definitive Agreement to Acquire Premier Antibody Portfolio and Engineering Capabilities Through Purchase of BioNovion

2015-09-23

arGEN-X’ Partner RuiYi, Inc. Announces First Human Dosing of Gerilimzumab, A Novel SIMPLE Antibody™ Against IL-6

2015-09-23

Nabriva Therapeutics Announces Closing of Its Initial Public Offerin

2015-09-21

Symbiomix Therapeutics Presents Data at ICAAC/ICC Demonstrating Oral Pharmacokinetics of Lead Product SYM-1219 Administered With and Without Food

2015-09-21

Pieris Pharmaceuticals Presents Positive Preclinical Data on Lead Bispecific Immuno-Oncology Program

2015-09-17

Corvus Pharmaceuticals Completes $75 Million Series B Financing

2015-09-17

"Cerenis Therapeutics is joining the Euronext indexes CAC Small, CAC

2015-09-17

Dimension Therapeutics Announces FDA Fast Track Designation for Lead Candidate DTX101 in Patients with Hemophilia B

2015-09-16

Google, OrbiMed buy into Alector’s novel take on Alzheimer’s with a $32M round

2015-09-15

ViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital

2015-09-15

Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

2015-08-24

SI-BONE, Inc. Announces Three Significant Clinical Evidence Publications on iFuse Implant System® for MIS SI Joint Fusion

2015-08-21

Seres Therapeutics, Inc. Announces FDA Orphan Drug Designation for SER-109 for the Prevention of Recurrent Clostridium Difficile Infection in Adults

2015-08-19

ViewRay® (VRAY) Completes Private Placement, Raises Aggregate of $29.4 Million

2015-08-19

Arsanis Appoints Rene Russo to Executive Team; Strengthens Board of Directors with Industry Veterans Amy Schulman and Dan Burgess

2015-08-18

Pieris Pharmaceuticals Appoints Louis A. Matis, M.D., as Chief Development Officer

2015-08-17

SAGE Announces First Patient Treated in Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus

2015-08-14

Practice Fusion Announces CEO Transition

2015-08-13

Invitae and collaborators announce publication of new data showing the clinical actionability of multi-gene panel testing for hereditary breast and ovarian cancer risk in JAMA Oncology

2015-08-13

Practice Fusion Partners with Stanford University to Help Discover Common Acid Reflux Drugs Potentially Associated with Increased Risk of Heart Attack

2015-08-13

Announcing TigerText for Apple Watch in iOS 5.3

2015-08-11

Dimension Therapeutics Expands Its Board of Directors with the Elections of Industry Leaders

2015-08-10

Health Canada Approves the Glaukos iStent Inject®

2015-08-10

Aduro Biotech Completes Enrollment in Phase 1b Clinical Trial of CRS-207 Immunotherapy for the Treatment of Mesothelioma

2015-08-10

Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States

2015-08-10

Relypsa and Vifor Fresenius Medical Care Renal Pharma Enter Into Partnership to Commercialize Patiromer FOS in Europe and Additional Territories

2015-08-07

Symbiomix Therapeutics’ First Pivotal Trial Results for SYM-1219 for Bacterial Vaginosis Presented at IDSOG

2015-08-06

Avitide Secures Series C Financing to Expand On-Demand Biopharmaceutical Affinity Purification Platform and Achieve Profitability

2015-08-06

SAGE Receives Special Protocol Assessment for Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus

2015-08-06

GLAUKOS CORPORATION ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN U.S. PIVOTAL CLINICAL TRIAL FOR ISTENT INJECT®

2015-08-06

Dimension Therapeutics Further Expands Leadership Team; Appoints Accomplished Industry Leader Jean M. Franchi as Chief Financial Officer

2015-08-05

InspireMD Announces Distribution Partnership of its CGuardTM Embolic Prevention System with Penumbra, Inc.

2015-08-05

SNS FIRE CONFERENCE NAMES TRUE NORTH THERAPEUTICS A 2015 FIRESTARTER COMPANY

2015-08-05

Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer

2015-07-30

Loxo Oncology Appoints Industry Veteran Tim Mayleben to Board of Directors

2015-07-30

arGEN-X and University of Bern enter into license agreement to develop ARGX-110-based combination therapies for treatment-resistant cancers

2015-07-30

GLAUKOS CORPORATION RECEIVES REGULATORY APPROVAL IN AUSTRALIA FOR ISTENT INJECT®

2015-07-30

Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency

2015-07-30

Cleave Biosciences Granted Key U.S. Patent Covering CB-5083

2015-07-30

Practice Fusion Expands Leadership Team and Board with Industry Veterans from Google, Amazon, WebMD, Quest Diagnostics, and Zendesk

2015-07-28

Otonomy Initiates Phase 2 Clinical Trial for AuriPro(TM) in Second Label Expansion Indication

2015-07-28

Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock

2015-07-27

University of Colorado Cancer Center and Loxo Oncology Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer

2015-07-23

ViewRay Completes Alternative Public Offering, Raises $26.7 Million

2015-07-22

Invitae announces online publication of data comparing traditional and multi-gene panel testing for hereditary breast and ovarian cancer in The Journal of Molecular Diagnostics

2015-07-21

Intercept Pharmaceuticals Appoints Richard Kim as Senior Vice President, Commercial Head of U.S.

2015-07-21

Biotie announces start of tozadenant Phase 3 Study in Parkinson's disease

2015-07-21

ProNAi Therapeutics Announces Closing of IPO and Full Exercise of the Underwriters' Option to Purchase Additional Shares

2015-07-20

Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence, Clinical Activity and Tolerability in Clinical Study in Multiple Myeloma Patients

2015-07-14

JAMA Publishes Long-Term Safety and Efficacy Results of Trial With Relypsa's Patiromer FOS Over One Year

2015-07-13

Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma

2015-07-10

EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ

2015-07-08

Pieris to Receive Seventh Milestone Payment From Daiichi Sankyo Collaboration to Develop Anticalin(R) Therapeutics

2015-07-08

Aeglea Biotherapeutics Appoints Sandy Mahatme and Russell Cox to Board of Directors

2015-07-07

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

2015-07-06

Pieris Pharmaceuticals Closes Public Offering of Common Stock

2015-07-02

Adaptimmune Announces FDA Acceptance of Investigational New Drug (IND) Application for MAGE-A10 T in Patients with Non-small Cell Lung Cancer

2015-07-01

Former Pharmacyclics CEO Raises $33.5M Series A for Corvus Pharmaceuticals

2015-07-01

Seres Therapeutics Announces Closing of Initial Public Offering

2015-06-30

GLAUKOS CORPORATION ANNOUNCES CLOSING OF ITS INITIAL PUBLIC OFFERING

2015-06-30

VIEWRAY SECURES UP TO $50M IN DEBT FINANCING FROM CRG

2015-06-29

Cynapsus Therapeutics Enrolls First Patient in Pivotal Phase 3 Efficacy Study Evaluating Sublingual, Film Strip Delivery of Apomorphine to Turn Parkinson’s Disease Patients from the OFF to the ON State

2015-06-29

Aduro Biotech Announces Immunotherapy Regimen Successfully Passes Futility Analysis in Phase 2b ECLIPSE Trial in Metastatic Pancreatic Cancer

2015-06-29

Intercept Pharmaceuticals Submits Applications in the U.S. and Europe for Marketing Approval of Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

2015-06-25

Cynapsus Therapeutics’ APL-130277 Improved Parkinson’s Symptoms and Rapidly Turned Patients from OFF to ON in Data Presented at the International Congress of Parkinson's Disease and Movement Disorders

2015-06-23

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

2015-06-23

Cynapsus Therapeutics Inc. Closes US$72.5 Million Public Offering of Common Shares in the United States

2015-06-23

ProNAi Appoints Dr. Barbara Klencke as Chief Development Officer

2015-06-23

Clementia Pharmaceuticals Raises U.S. $60 Million in Mezzanine Financing to Support Development of Palovarotene for Fibrodysplasia Ossificans Progressiva

2015-06-18

Sikka Software Raises $10.5 Million Series C Round to Increase its Rapidly Expanding Share of Cloud-based Retail Healthcare

2015-06-18

Selecta Biosciences' Synthetic Vaccine Particles Instrumental in Breakthrough Research on Mucosal Vaccines

2015-06-18

ProNAi Appoints Dr. Nicole Onetto and Mr. Robert Pelzer to its Board of Directors

2015-06-18

Practice Fusion Launches Native iOS and Android Applications; Only Meaningful Use-Certified EHR Available on 3 Platforms: Desktop, iOS and Android

2015-06-18

Preliminary Phase I results of ARGX-110 in patients with T-cell lymphomas presented at ICML

2015-06-18

Practice Fusion is the Market Share Leader for Solo and Small Clinician Practices

2015-06-16

Biotie Announces Closing of U.S. Public Offering and Conversion of Convertible Notes

2015-06-16

ProNAi Strengthens Leadership Team; Opens Vancouver Corporate Headquarters

2015-06-15

Glaukos Corporation Announces Launch of Initial Public Offering

2015-06-15

PRINCIPIA BIOPHARMA PRESENTS FULL PHASE 1 CLINICAL TRIAL RESULTS FOR PRN1008, A NOVEL REVERSIBLE COVALENT BTK INHIBITOR, SUPPORTING FURTHER CLINICAL DEVELOPMENT IN AUTOIMMUNE AND INFLAMMATORY DISEASES

2015-06-15

Adimab Establishes New Collaboration with Kite Pharma for the Discovery of Antibodies for T-cell Therapies

2015-06-12

ProNAi Therapeutics Files Registration Statement for Proposed Initial Public

2015-06-12

Biotie Announces Exercise of Over-allotment Option

2015-06-12

Seres Therapeutics Receives FDA Breakthrough Therapy Designation for Its Lead Product Candidate, SER-109

2015-06-11

Biotie Announces Completion of Pricing of U.S. Public Offering of ADSs and Conversion of Convertible Notes

2015-06-10

Selecta Biosciences Initiates Phase 1 Clinical Program of SEL-212, Designed As the First Non-Immunogenic Biologic Treatment for Gout

2015-06-10

Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia

2015-06-09

SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression

2015-06-09

Cerenis Therapeutics announces new Board members

2015-06-09

Symbiomix Therapeutics Doses First Patient in Confirmatory Phase 3 Pivotal Study of Lead Drug Candidate SYM-1219 for Bacterial Vaginosis

2015-06-09

Cynapsus Therapeutics Inc. Announces Launch of Proposed Public Offering of Common Shares in the United States

2015-06-08

Good Start Genetics Publishes Variant Database Validation Study

2015-06-04

Cynapsus Therapeutics Announces Issuance of U.S. Patent Providing Broad Coverage for Sublingual Apomorphine

2015-06-02

Aduro Biotech Appoints Liana Wu as Vice President of Commercial

2015-06-01

ARMO BioSciences Announces Efficacy and Safety Data for Immuno-Oncology Program with Novel Mechanism of Action

2015-06-01

SI-BONE, Inc. Announces iFuse MIS SI Joint Fusion Gains Support from North American Spine Society (NASS) with Positive Coverage Policy Recommendation

2015-06-01

Invitae launches new patient pay price of $475 for its full menu of genetic tests

2015-05-30

Adaptimmune Announces Data from Clinical Studies of NY-ESO-1 Specific T-Cells in Multiple Cancers at the 2015 Annual American Society of Clinical Oncology (ASCO) Meeting

2015-05-30

Initial Data from Ongoing Expansion Study of MGCD265 Show Preliminary Evidence of Clinical Efficacy in Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients with MET Gene Alterations

2015-05-29

arGEN-X presents preliminary efficacy and expanded safety data from Phase I trial of ARGX-111 at ASCO

2015-05-28

Chicago Cardiology Institute Deploys TigerText to Accelerate Clinician Response Times

2015-05-28

Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva

2015-05-26

Cerenis Therapeutics featured prominently at the International Symposium on Atherosclerosis (IAS)

2015-05-26

SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital

2015-05-25

Biotie announces agreement with FDA on a Special Protocol Assessment for tozadenant Phase 3 study

2015-05-21

Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology

2015-05-21

Otonomy Reports Phase 2b Topline Data for OTO-104 in Meniere's Disease

2015-05-21

arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions

2015-05-19

arGEN-X awarded €1.5 million IWT grant to advance the application of NHance Fc modifications in therapeutic antibodies

2015-05-19

New Data Shows Advantages of Acutus Medical Dipole Density Heart Imaging and Mapping System Compared to Standard Voltage-based Mapping in Patients with Atrial Flutter

2015-05-19

Practice Fusion and the American Urological Association Collaborate to Launch Overactive Bladder Population Health Management Initiative

2015-05-19

Intercept Pharmaceuticals Announces Pivotal Phase 3 Clinical Trial of Obeticholic Acid in NASH

2015-05-14

PIERIS PHARMACEUTICALS APPOINTS IMMUNO-ONCOLOGY EXPERT, HOLBROOK KOHRT, M.D., PH.D., TO SPEARHEAD IMMUNO-ONCOLOGY EFFORTS AND INITIATES RESEARCH COLLABORATION WITH LEADING CANCER RESEARCH CENTER

2015-05-14

SAGE Therapeutics Achieves 77 Percent Response Rate in Completed Phase 1/2 Clinical Trial of SAGE-547 in Super-Refractory Status Epilepticus

2015-05-13

Glaukos CorporationFiles Registration Statement for

2015-05-13

Selecta and Genethon Collaborate to Create Next Generation Gene Therapies Using Selecta’s Synthetic Vaccine Particle Platform

2015-05-12

InspireMD’s CGuard™ Highlighted at Clinical Presentation at EuroPCR 2015 Conference

2015-05-12

TigerText Joins the Box Assured App Ecosystem

2015-05-11

Adaptimmune Announces Closing of Initial Public Offering

2015-05-07

Adimab Establishes New Partnership with Celgene for Discovery of Antibodies and Bispecifics for Next-Generation Therapeutics for Patients

2015-05-07

Otonomy Completes Enrollment in Phase 2 Clinical Trial for AuriPro(TM) in Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes

2015-05-07

Aduro Biotech's Preclinical Results for Its STING-Targeted CDN Immuno-Oncology Platform Highlighted in Prestigious Peer-Reviewed Publications

2015-05-04

SI-BONE, Inc. Announces Medicare Contractor Cahaba to issue positive coverage of MIS SI Joint Fusion

2015-05-04

Sonendo Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System

2015-05-04

Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis

2015-04-30

Singulex Announces Partnership with The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers - See more at: http://www.singulex.com/singulex-press-releases/#sthash.DrsY2zSd.dpuf

2015-04-28

Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil

2015-04-28

Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers - See more at: http://www.singulex.com/singulex-press-releases/#sthash.HjNUj8Xg.dpuf

2015-04-28

Otonomy Announces FDA Acceptance of AuriPro(TM) New Drug Application

2015-04-27

InspireMD Announces MGuard™ Prime Approval in Brazil

2015-04-27

Invitae appoints Robert Nussbaum, M.D. as Chief Medical Officer

2015-04-27

Otonomy Presents AuriPro(TM) Phase 3 Results at American Society of Pediatric Otolaryngology Conference

2015-04-23

Dimension Therapeutics to Develop Gene Therapy Treatments for Patients with Ornithine Transcarbamylase (OTC) Deficiency and Glycogen Storage Disease Type Ia (GSDIa)

2015-04-23

arGEN-X Announces Publication on Therapeutic Potential of ARGX-115 in Cancer Immunotherapy

2015-04-23

Intercept Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution and Cirrhosis Prevention in High-Risk NASH Patients

2015-04-21

SAGE Therapeutics Announces Closing of $138 Million Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares

2015-04-21

Loxo Oncology’s LOXO-101 Demonstrates Encouraging Initial Results From Ongoing Phase 1a Dose Escalation Study

2015-04-21

Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors

2015-04-21

Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing

2015-04-20

Aduro Biotech Announces Close of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Concurrent Private Placement

2015-04-20

Otonomy Completes Enrollment of OTO-104 Multiple-Dose Safety Study in Meniere's Disease Patients

2015-04-20

SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol to Evaluate SAGE-547 in Patients With Super-Refractory Status Epilepticus

2015-04-14

Aduro Biotech Announces Pricing of Its Initial Public Offering

2015-04-14

SAGE Therapeutics Announces Pricing of Public Offering of Common Stock

2015-04-14

Practice Fusion and ePatientFinder Partner to Launch One of the Nation’s Largest EHR-Based Clinical Trial Networks

2015-04-14

TigerText Introduces First Secure Enterprise Messaging App for the Apple Watch

2015-04-14

arGEN-x N.V. Announces Changes to the Board of Directors

2015-04-13

GOOD START GENETICS ENTERS EXCLUSIVE LICENSE AGREEMENT WITH

2015-04-10

CardiAQ™ Valve Technologies receives FDA IDE Approval for a US Early Feasibility Study of Its Second-Generation Transfemoral and Transapical Transcatheter Mitral Valve Implantation Systems

2015-04-09

arGEN-X Opens Expansion Cohort in Phase 1b Study of ARGX-111 in Patients with MET Amplified Cancers

2015-04-09

Singulex Announces Collaboration with CHDI Foundation to Develop Biomarker Assays for Huntington’s Disease

2015-04-08

Relypsa Presents New Data on the Importance of Renin-Angiotensin-Aldosterone-System Inhibitor (RAASi) Therapy in Patients With Cardio-Renal Comorbidities at the Academy of Managed Care Pharmacy's 27th Annual Meeting

2015-04-07

Nabriva Announces Financing of up to $120M to Advance Clincial Development of New Class of Antibiotic

2015-04-07

True North Therapeutics Announces $35 Million Series B Financing

2015-04-07

Cerapedics Announces Closing of Loan and Equity Financing

2015-04-07

Cerapedics Announces Closing of Loan and Equity Financing

2015-04-06

Intercept Pharmaceuticals Announces Completion of Public Offering

2015-04-02

SAGE Therapeutics Announces Positive End-of-Phase 2 Meeting With FDA and Planned Initiation of SAGE-547 Global Phase 3 Trial in Mid-2015

2015-04-02

Clementia Advances Phase 2 Clinical Trial of Palovarotene in Fibrodysplasia

2015-04-01

Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer

2015-03-30

PIERIS PHARMACEUTICALS AND THE UNIVERSITY OF MELBOURNE RECEIVE RESEARCH GRANT TO ADVANCE IMMUNOLOGICAL DISEASES PROGRAM

2015-03-30

Aduro Biotech Establishes Major Collaboration with Novartis for Global Research, Development and Commercialization of Immuno-Oncology Products Derived from its Proprietary STING-Targeted CDN Platform Technology

2015-03-26

PIERIS PHARMACEUTICALS REPORTS FULL-YEAR 2014 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

2015-03-26

Aduro Receives Orphan Drug Designation for CRS-207 in Mesothelioma

2015-03-26

Invitae presents new data demonstrating use of next-generation sequencing for multi-gene panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting

2015-03-26

Relypsa Presents Sub-Group Analysis From Phase 3 Study of Patiromer FOS in Patients With Advanced Chronic Kidney Disease at 2015 National Kidney Foundation Spring Clinical Meeting

2015-03-26

Otonomy Initiates Phase 2 Clinical Trial for AuriPro(TM) in Label Expansion Indication

2015-03-25

Practice Fusion Adds Medi-Span Drug Database to EHR Platform Impacting 4 Million e-Prescriptions a Month

2015-03-24

SI-BONE, Inc. Adds SI Joint Specific Patent to IP Portfolio - Total U.S. Issued Patents now 16

2015-03-23

Aeglea Biotherapeutics Raises $44 Million in Series B Financing

2015-03-20

Intercept Announces New Data Analyses From FLINT Trial of Obeticholic Acid in NASH

2015-03-20

Intercept Announces New Data Analyses From FLINT Trial of Obeticholic Acid in NASH

2015-03-15

Data Presented at ACC Demonstrates Benefits of Keystone Heart’s TriGuard™ Cerebral Protection Device during TAVR

2015-03-14

Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session

2015-03-10

Adaptimmune appoints Lawrence M. Alleva to its Board of Directors

2015-03-09

SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants

2015-03-04

arGEN-X Expands Preclinical Pipeline with ARGX-115: A Novel Simple Antibody™ for Cancer Immunotherapy

2015-03-04

Tricida Announces Closing of $30M Series B Financing

2015-03-04

Adaptimmune Strengthens Management Team with Key Executive Hires

2015-03-03

Relypsa Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

2015-03-03

TigerText Launches TigerConnect Secure Messaging Platform

2015-03-02

SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone

2015-03-02

Loxo Oncology Announces 2015 Program Guidance and Reveals Selected Pipeline Programs

2015-02-26

Otonomy Submits New Drug Application to the FDA for AuriPro™

2015-02-18

TigerText Named to Verizon Partner Program

2015-02-18

Invitae announces completion of initial public offering and full exercise of underwriters’ option to purchase additional shares

2015-02-18

Lonza and arGEN-X Announce a Multi-product GS Xceed™ License Agreement for Therapeutic Antibodies

2015-02-17

CoverMyMeds and Practice Fusion Partner to Bring Electronic Prior Authorizations for Medications to Over 110,000 of Practice Fusion’s Users

2015-02-13

SAGE Therapeutics Appoints New Vice Presidents to Lead Key Organizational Functions

2015-02-12

Practice Fusion Releases Online Check-In, eliminating the need for patients to fill out paper forms in the doctor’s office

2015-02-09

Cerenis Therapeutics announces the appointment of a new Chief Medical Officer and new Board Members

2015-02-05

Clementia Completes Enrollment Of First Cohort In Phase 2 Clinical Trial

2015-02-04

Intercept Pharmaceuticals Announces Pricing of Public Offering

2015-02-04

Implementing the GentleWave™ System by Sonendo®

2015-02-03

VIEWRAY RECEIVES FIRST EUROPEAN ORDER FOR ITS MRIDIAN SYSTEM

2015-02-03

Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

2015-02-02

Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

2015-02-02

Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

2015-01-29

Intercept Receives Breakthrough Therapy Designation From FDA for Obeticholic Acid for Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis

2015-01-29

PMV Pharma Named An Innovative Startup of 2014 by BioEntrepreneur

2015-01-28

Dimension Therapeutics Appoints Successful Biopharma Leader Mary Thistle as Chief Business Officer

2015-01-28

Dimension Therapeutics Appoints Successful Biopharma Leader Mary Thistle as Chief Business Officer

2015-01-28

Otonomy Announces Closing of Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

2015-01-26

Invitae announces settlement in lawsuit with Myriad Genetics

2015-01-22

Relypsa Announces Helen Torley, M.B. Ch.B., M.R.C.P. Joins Board of Directors

2015-01-14

Cerapedics Receives CE Mark and TGA Listing for New i‐FACTOR™ Flex FR Biologic Bone Graft

2015-01-14

Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil

2015-01-14

Casa de la Luz Hospice Adopts TigerText to Speed Response Times

2015-01-14

Practice Fusion Announces Positive Results of Population Health Vaccine Initiative Conducted in Collaboration with Merck

2015-01-13

ITOCHU NAMED THE EXCLUSIVE DISTRIBUTOR FOR VIEWRAY’S MRI-GUIDED RADIATION THERAPY SYSTEM IN JAPAN

2015-01-13

Dr. Evan Chaney to present on Salmonella enterica Detection in Poultry Matrices at IPPE

2015-01-13

Practice Fusion and OptimizeRx Partner to Help Providers Improve Patients’ Access and Adherence to Medication

2015-01-12

Principia Biopharma Appoints Roy Hardiman As Chief Business Officer And Lewis Shuster To Board Of Directors

2015-01-12

Clementia Pharmaceuticals Opens Clinical Trial Site in Europe for Phase 2 Study

2015-01-12

Practice Fusion Signs 120th Revenue-Generating Deal with a Radiology Partner for its Electronic Health Records (EHR) Platform to Become Largest Hub Connecting Imaging Centers and Providers in the U.S.

2015-01-12

SAGE Therapeutics Initiates Phase 2a Trial of SAGE-547 in Postpartum Depression

2015-01-12

arGEN-X Launches Innovative Access Program

2015-01-12

Loxo Oncology Appoints Alan Fuhrman to Board of Directors

2015-01-09

Invitae Corporation files registration statement for proposed initial public offering

2015-01-09

Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza

2015-01-09

Invitae Corporation files registration statement for proposed initial public offering

2015-01-09

SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial and Emergency Use Program of SAGE-547 in Patients With Super-Refractory Status Epilepticus

2015-01-08

Principia Biopharma Successfully Completes Phase 1 Clinical Trial Of PRN1008, A Novel Oral BTK Inhibitor For Autoimmune Diseases

2015-01-08

Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Advanced Solid Tumors

2015-01-07

ProNAi Initiates Phase II Trial of PNT2258 in Patients with Relapsed or Refractory

2015-01-07

Mirati Therapeutics Doses First Patient in Phase 2 Study of Mocetinostat in Bladder Cancer Patients with Genetic Alterations of CREBBP and EP300

2015-01-06

Mirati Therapeutics Doses First Patient in Investigator-Sponsored Phase 2 Study of Mocetinostat in Non-Hodgkin's Lymphoma

2015-01-05

SI-BONE, Inc. Announces Medicare Noridian Reimbursing for MIS SI Joint Fusion

2015-01-05

Clementia Pharmaceuticals Raises $10 Million In Extension Of Series A Financing To Support Development Of Palovarotene For Fop – Company Opens New Subsidiary To Serve U.S. Market

2015-01-05

Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension

2014-12-23

Mirati Therapeutics Doses First Patient in Expansion Cohorts of Phase 1b Trial of MGCD265 in Genetically Selected Patients

2014-12-23

Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle in the Field of Immuno-oncology

2014-09-04

Mirati Therapeutics Initiates Phase 1 Study of MGCD516 for Non-Small Cell Lung Cancer and Other Advanced Solid Tumors

2014-09-04

Tricida Announces In-House Discovered Clinical Candidate in Cardiorenal Disease

2014-09-04

Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma

2014-09-03

Cerenis Receives EMA Orphan Drug Designation for CER-001 for the Treatment of ApoA-I and ABCA-1 Deficiencies

2014-09-03

Cerenis Appoints Dr. Richard C. Pasternak as Chairman

2014-09-03

Durata Therapeutics to Present Safety and Efficacy Data at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

2014-09-03

Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference

2014-09-02

Affimed Secures $29.7M in Private Financing from Current and New Investors

2014-09-02

Aerpio Therapeutics Announces Publication of Preclinical Data on AKB-9778 for Common Eye Diseases

2014-08-27

arGEN-X – Business Update and First Half 2014 Results

2014-08-27

Civitas Therapeutics Files Registration Statement for Proposed Initial Public Offering

2014-08-27

Singulex Announces Preview of the Sgx ClarityTM IVD System and Presentation of 10 Abstracts Demonstrating Single Molecule (SMCTM) Technology Performance in Cardiovascular Disease at 2014 ESC Congress

2014-08-27

TigerText Growth Accelerates in First Half of 2014 as Message Volume Surges 750%

2014-08-26

Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors

2014-08-26

Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires

2014-08-25

Biodel Appoints Gary G. Gemignani as Chief Financial Officer

2014-08-25

Civitas Therapeutics Secures $55 Million in Series C Financing

2014-08-25

Practice Fusion and Vitals Partner to Bring Online Appointment Booking and Doctor Reviews to Millions of Americans

2014-08-20

NxStage Kidney Care Opens New Orlando Florida Dialysis Center

2014-08-19

arGEN-X announces positive preclinical results for ARGX-113

2014-08-13

Otonomy Announces Pricing of Initial Public Offering

2014-08-12

Acceleron Pharma Reports Second Quarter 2014 Financial Results

2014-08-12

Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor

2014-08-12

Ambit Biosciences Announces Second Quarter 2014 Operating Results

2014-08-11

Biodel Reports Third Quarter Fiscal Year 2014 Financial Results

2014-08-11

Relypsa Announces Second Quarter 2014 Financial Results

2014-08-11

InspireMD to Announce Results of CGuard™CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

2014-08-11

Intercept Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business Update

2014-08-11

Mirati Therapeutics Receives Orphan Designation from U.S. Food & Drug Administration for Mocetinostat in Diffuse Large B-Cell Lymphoma

2014-08-11

Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Glucose Control Following Standardized Meals Compared to Marketed Insulins in a Phase 2 Clinical Trial in Patients With Type 2 Diabetes

2014-08-08

Mirati Therapeutics Reports Second Quarter 2014 Financial Results and Provides Business Update

2014-08-07

Durata Therapeutics Reports Second Quarter 2014 Financial Results

2014-08-07

Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations

2014-08-07

Igenica Biotherapeutics Awarded SBIR Grant for Next Generation Antibody Drug Conjugate Technology

2014-08-07

NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance

2014-08-06

Practice Fusion Acquires Ringadoc

2014-08-01

Loxo Oncology Announces Pricing of Initial Public Offering

2014-07-31

Revolutionary Radiation Therapy System From Viewray Is Acquired By Sylvester Comprehensive Cancer Center At The University Of Miami

2014-07-30

Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey

2014-07-28

CIOsynergy Announces TigerText as Official Sponsor for its August 14th, 2014 CIOhealth Event

2014-07-28

Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update

2014-07-28

Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial for Heart Failure Drug CXL-1427

2014-07-28

Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital

2014-07-25

Ferdinand Verdonck Elected to Affimed’s Supervisory Board

2014-07-24

Clementia Pharmaceuticals Receives U.S. Orphan Drug Designation For Palovarotene For The Treatment Of Fibrodysplasia Ossificans Progressiva

2014-07-23

InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2014

2014-07-23

Singulex Highlights Development Progress With Ultrasensitive Sgx ClarityTM System at AACC 2014

2014-07-23

SAGE Therapeutics Announces Closing of Initial Public Offering

2014-07-22

SAGE Therapeutics Receives Fast Track Designation for Lead Compound SAGE-547 to Treat Status Epilepticus

2014-07-22

CIOsynergy Announces TigerText as Official Sponsor for its August 14th, 2014 CIOhealth Event

2014-07-21

SAGE Therapeutics Announces Full Exercise of Over-Allotment Option

2014-07-21

Multi-Center Trial Shows Significant Pain Relief For Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment

2014-07-18

Durata Therapeutics Announces the U.S. Launch of DALVANCE™

2014-07-17

Roka Bioscience Announces Pricing of Initial Public Offering

2014-07-17

Loxo Oncology Expands Leadership Team with Key Executive Appointments in Finance, R&D, and Corporate Development

2014-07-17

Practice Fusion Signs 122 Partnership Deals with Health System, Hospital, Lab and Imaging Clients in 2014

2014-07-17

SAGE Therapeutics Announces Pricing of Initial Public Offering

2014-07-15

InspireMD Appoints Dr. James Barry as Chief Operating Officer

2014-07-14

Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

2014-07-14

Clementia Pharmaceuticals Initiates Phase 2 Study Of Palovarotene In Patients With Fibrodysplasia Ossificans Progressiva (FOP)

2014-07-14

Otonomy Files Registration Statement for Proposed Initial Public Offering

2014-07-14

Acceleron Pharma Appoints Terrence C. Kearney to its Board of Directors

2014-07-08

InspireMD Announces Successful Completion of CGuardTM CARENET (CARotid Embolic protection study using microNET) Trial

2014-07-08

Otonomy Announces Positive Results from Two Phase 3 Trials of AuriPro™ in Pediatric Patients Undergoing Ear Tube Placement Surgery

2014-07-07

CardiAQ™ Valve Technologies, Inc. announces that it has obtained a stay of further proceedings in Neovasc Inc.’s pending European patent application covering Transcatheter Mitral Valve Replacement

2014-07-02

InspireMD Selected for Inclusion in the Russell Microcap Index

2014-06-30

Mirati Therapeutics Added to Russell 2000 Index

2014-06-30

Affimed Files Registration Statement for Proposed Initial Public Offering

2014-06-25

Practice Fusion and Emdeon Team Up to Simplify Medical Claim Filings on Practice Fusion’s Electronic Health Record (EHR) Platform

2014-06-23

Dimension Therapeutics Raises $30M Financing

2014-06-23

Dimension Therapeutics and Bayer HealthCare Enter Collaboration to Develop Novel Gene Therapy for Hemophilia A

2014-06-23

Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors

2014-06-23

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuardTM Prime EPS

2014-06-20

Adimab Announces 50th Therapeutic Program Under Its Funded Discovery Partnerships

2014-06-19

Relypsa Adds Industry Veterans Daniel K. Spiegelman and Kenneth J. Hillan to Its Board of Directors

2014-06-17

Boston Children’s Hospital Chooses TigerText to Accelerate Staff Communication and Workflows

2014-06-17

Mirati Therapeutics Receives Orphan Drug Designation from U.S. Food & Drug Administration for Mocetinostat in Myelodysplastic Syndrome

2014-06-17

Practice Fusion Expands Executive Bench, Adding Chief Financial Officer

2014-06-17

Selecta Biosciences Enters Into Exclusive License Agreement with 3SBio to Develop Drug Candidate to Treat Gout

2014-06-17

Selecta Biosciences to Accelerate Program for Novel Dual Action Vaccine for Malaria with support from the Bill & Melinda Gates Foundation

2014-06-17

Selecta Accelerates Immune Tolerance Therapeutics and Announces New Product Candidate, SEL-212, for Refractory and Tophaceous Gout

2014-06-16

Cleave presents poster at 2014 FASEB Ubiquitin and Cell Regulation Meeting

2014-06-16

BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment

2014-06-16

Practice Fusion Named One of the Bay Area’s Top Workplaces

2014-06-14

STUDIES PRESENTED AT 19TH EUROPEAN HEMATOLOGY ASSOCIATION ANNUAL CONGRESS EVALUATE ACTIVIN RECEPTOR LIGAND TRAP PROGRAMS IN BETA-THALASSEMIA

2014-06-13

Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors

2014-06-12

Ambit Biosciences Announces Presentation Of Data From Clinical Investigations Of Quizartinib At The 19th Congress Of The European Hematology Association

2014-06-11

Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa®

2014-06-11

BioLineRx Receives Notice of Allowance for US Patent Covering Novel Treatment for Celiac Disease

2014-06-10

Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions

2014-06-10

SAGE Therapeutics Appoints James M. Frates to the Company's Board of Directors

2014-06-10

arGEN-X and The Leukemia & Lymphoma Society Partner on the Development of ARGX-110 for the Treatment of Waldenström’s Macroglobulinemia

2014-06-06

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

2014-06-05

RedHill Biopharma Announces New RHB-104 Patent in Japan and Provides Update on Phase III Crohn’s Program

2014-06-05

SAGE Therapeutics Presents Preliminary SAGE-547 Clinical Data at Epilepsy Pipeline Conference

2014-06-04

arGEN-X enters long-term strategic alliance with Shire Pharmaceuticals in therapeutic antibodies

2014-06-04

New England Journal of Medicine Publishes Data From Durata Therapeutics' Discover Program

2014-06-04

Ambit Biosciences Announces Changes To Board Of Directors

2014-06-03

Ambit Biosciences Announces Presentation of Data from Clinical Investigations of Quizartinib at the 2014 Annual Meeting of The American Society Of Clinical Oncology

2014-06-02

Cerenis Reports Two Positive Phase II Studies for HDL Mimetic CER-001 at EAS

2014-06-02

Relypsa Secures Loan Facility of Up to $35 Million

2014-05-29

arGEN-X to present results of Phase 1 study of ARGX-110, a novel anti-CD70 antibody, in patients with advanced cancer at ASCO

2014-05-28

arGEN-X announces collaboration with Bayer to discover and develop therapeutic antibody candidates

2014-05-28

Intercept Announces that FDA Grants Fast Track Designation to Obeticholic Acid for the Treatment of Patients with Primary Biliary Cirrhosis

2014-05-27

MacroGenics and Takeda Enter Strategic Alliance to Develop DART for Treatment of Autoimmune Disorders

2014-05-27

Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System

2014-05-23

FDA Approves Durata Therapeutics' DALVANCE(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults

2014-05-22

RedHill Biopharma Announces FDA Clearance for Phase III Study with RHB-102 Planned to Commence in Q3/2014

2014-05-21

RedHill Biopharma and IntelGenx Report Positive RHB-103 Bioavailability Study Results in Support of Planned European Marketing Application in Q3/2014

2014-05-21

Practice Fusion Launches Nation’s Largest Real-Time Healthcare Database

2014-05-21

Singulex Appoints Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer - See more at: http://www.singulex.com/singulex-press-releases/#sthash.S2NQx92W.dpuf

2014-05-21

Acceleron Announces New Interim Phase 2 Data on Sotatercept and ACE-536 to be Reported at Three Oral Presentations at the 19th Annual Congress of the European Hematology Association

2014-05-20

Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals

2014-05-20

"CardiAQ™ Valve Technologies reports Successful First-in-Human Trans-Apical implantation of its Second Generation Transcatheter Mitral Valve"

2014-05-20

InspireMD to Showcase Embolic Systems with MicroNetTM Technology and Results from MASTER I Trial at EuroPCR Conference

2014-05-20

Crown Bioscience to showcase progression in human surrogate trials at the 50th ASCO Annual Meeting

2014-05-19

Audentes Therapeutics Announces Six Abstracts to be Presented at the American Society of Gene and Cell Therapy Meeting May 21-24, 2014

2014-05-15

Keystone Heart Raises $14M in Series B Funding for Cerebral Protection Devices

2014-05-15

Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes

2014-05-15

Inspire Medical Systems Raises $40 Million in Series E Funding

2014-05-15

Mirati Therapeutics Reports First Quarter 2014 Financial Results and Provides Business Update

2014-05-15

Acceleron Pharma Reports First Quarter 2014 Financial Results

2014-05-15

Crown Bioscience receives $26.55 million in Series D Funding

2014-05-15

Inspire Medical Systems Raises $40 Million in Series E Funding

2014-05-14

New Janssen Labs Incubator Could Bring Up to 50 Companies to South SF

2014-05-13

Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update

2014-05-13

Biodel Reports Second Quarter Fiscal Year 2014 Financial Results

2014-05-12

SI-BONE, Inc. Announces Medicare Novitas Removes MIS SI Joint Fusion from Non-Coverage

2014-05-12

Relypsa Announces Topline Results From Patiromer Phase 1 Onset-of-Action Study

2014-05-12

Response Biomedical Corp. Announces First Quarter 2014 Financial Results

2014-05-09

Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations

2014-05-08

Response Biomedical Corp. Announces Voting Results

2014-05-08

Durata Therapeutics Reports First Quarter 2014 Financial Results

2014-05-08

Crown Bioscience Announces Research Collaboration with the National Resource Center for Mutant Mice (NRCMM)

2014-05-08

NxStage Reports Record First Quarter 2014 Financial Results And Exceeds Guidance

2014-05-08

Otonomy Completes Enrollment of AuriPro™ Pivotal Studies in Pediatric Patients Undergoing Ear Tube Placement Surgery

2014-05-07

Intercept Pharmaceuticals Reports First Quarter 2014 Financial Results

2014-05-07

Relypsa Announces First Quarter 2014 Financial Results

2014-05-06

MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results

2014-05-06

Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week

2014-05-06

Loxo Oncology Closes a $24 Million Series B Financing and Expands Management Team

2014-05-06

Ambit Biosciences Announces First Quarter 2014 Operating Results

2014-05-05

Aerpio Therapeutics Presents Full Results from Phase 1b/2a Study of AKB-9778

2014-05-05

MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014

2014-05-05

SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Officer

2014-05-02

Acutus Medical, Inc. Announces CE Mark for New 3D Diagnostic Imaging and Mapping Catheter

2014-05-02

Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels

2014-05-01

Loxo Oncology Initiates Phase 1 Trial of LOXO-101, a Selective Trk Inhibitor

2014-05-01

SAGE Therapeutics Receives U.S. Orphan Drug Designation for Lead Compound SAGE-547 to Treat Status Epilepticus

2014-04-30

Otonomy Raises $49 Million in Oversubscribed Financing

2014-04-30

Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer

2014-04-30

RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3 2014

2014-04-30

RedHill Biopharma Reports Results for the First Quarter of 2014

2014-04-30

Cleave Presents Poster at 2014 Cold Spring Harbor Meeting on Molecular Chaperones & Stress Responses

2014-04-30

MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel

2014-04-28

SI-BONE, Inc. Closes $33 Million Growth Capital Financing

2014-04-28

RedHill Biopharma and IntelGenx Announce Commencement of a Bioavailability Study with RHB-103 (Migraine) to Support European Marketing Application Planned for Q3 2014

2014-04-28

Good Start Genetics Appoints Charles F. Wagner, Jr. to the Company’s Board of Directors - See more at: http://www.goodstartgenetics.com/about/news-coverage/#sthash.VBIBM0xF.dpuf

2014-04-28

Practice Fusion Teams with Merck on Population Health Management Initiative

2014-04-28

ALK enters collaboration to accelerate growth in China

2014-04-24

Durata Therapeutics Initiates Enrollment in a Phase 3b Study of Dalvance(TM) in a 1500 mg Single Dose

2014-04-24

Crown Bioscience Enters Japanese Market via Strategic Partnership with Shin Nippon Biomedical Laboratories

2014-04-24

RedHill Biopharma and IntelGenx Provide an Update on FDA’s Ongoing Review of the NDA for RHB-103 Oral Migraine Film

2014-04-24

Sientra and RealSelf Announce Exclusive Initiative to Deliver New Education to Women Seeking Breast Augmentation

2014-04-23

ExcelPaces Approved by Management Board of Royal College of Physicians

2014-04-23

Aerpio Therapeutics Closes $22M Financing

2014-04-23

Acceleron and Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Patients with End Stage Renal Disease on Hemodialysis

2014-04-23

Clementia Pharmaceuticals Marks Fibrodysplasia Ossificans Progressiva (FOP) Awareness Day

2014-04-22

Principia Biopharma Secures $50 Million Series B Financing

2014-04-22

Biodel Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation

2014-04-22

Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology

2014-04-22

Crown Bioscience Passes 1000 Model Mark in PDX Collection for Oncology Drug Discovery

2014-04-21

ProNAi Therapeutics Raises $59.5 Million Series D Financing

2014-04-19

InspireMD Announces First Patient Enrolled Into New CGuardTM CARENET (CARotid Embolic protection study using microNET) Clinical Trial

2014-04-16

Relypsa, Inc. Announces Closing of Public Offering of Common Stock

2014-04-15

TigerText Expands Its Board of Directors with Three New Members

2014-04-14

Cerapedics Announces Closing Of Venture Debt Loan From GE Capital

2014-04-14

Dimension Therapeutics Expands Leadership Team and Scientific Advisory Board with Key Appointments

2014-04-14

arGEN-X Appoints Dr Werner Lanthaler to its Supervisory Board

2014-04-12

Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session

2014-04-11

Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis

2014-04-10

Affimed highlights further data on AFM13 at the 2014 AACR Annual Meeting

2014-04-10

BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid Leukemia Treatment

2014-04-10

Relypsa, Inc. Announces Pricing of Public Offering of Common Stock

2014-04-08

CardiAQ™ Valve Technologies Inc. (CardiAQ) appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs

2014-04-08

Study Presented At Sages 2014 Shows Anterior Fundoplication With Medigus' Muse™ System Can Reduce Gerd Patients' Use Of Ppis

2014-04-08

Ambit Announces Initiation Of Quizartinib QUANTUM-R Phase 3 Trial

2014-04-08

NxStage® to Report First Quarter 2014 Financial Results

2014-04-08

Relypsa, Inc. Announces Proposed Public Offering of Common Stock

2014-04-08

AlSubiya KIMS Expansions in Saudi Arabia

2014-04-07

Ambit Announces Initiation Of Phase 2 Cohort In MD Anderson Sponsored Study Of Quizartinib In AML And High Risk MDS

2014-04-07

RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 and Plans to Submit a European Marketing Application

2014-04-07

arGEN-X uses its SIMPLE Antibody™ platform to identify four ‘hotspots’ on MET as targets for its therapeutic antibody program

2014-04-07

Report: Practice Fusion Named the No. 1 Electronic Health Records (EHR) Vendor in Primary Care Practices for Fifth Year Running

2014-04-04

Data From Intercept's Pivotal Phase 3 POISE Trial of Its FXR Agonist Obeticholic Acid to Treat Primary Biliary Cirrhosis and Other Key Obeticholic Acid Data to be Presented at EASL 2014

2014-04-03

Intercept Pharmaceuticals Announces Pricing of Public Offering

2014-04-02

Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs

2014-04-01

SAGE Therapeutics Appoints Howard H. Pien to the Company’s Board of Directors

2014-04-01

Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock

2014-03-31

Sony DADC and Singulex Announce Strategic Partnership for Proprietary Detection Vessels - See more at: http://www.singulex.com/singulex-press-releases/#sthash.CObq5IF4.dpuf

2014-03-31

TigerText Introduces $1 Million Guarantee Against HIPAA Violations

2014-03-31

Anthera Pharmaceuticals Announces Personnel Changes

2014-03-31

New Findings Highlight Good Start Genetics’ NGS Screening Capabilities in Ethnically Diverse Populations

2014-03-31

FDA Advisory Committee Unanimously Recommends Approval of Dalvance(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

2014-03-31

Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules

2014-03-27

SAGE Therapeutics Initiates Phase 1/2 Trial of SAGE-547 in Status Epilepticus

2014-03-27

PrimusLabs Strengthens Commitment to Food Safety Testing with Adoption of Roka Bioscience’s Atlas® System

2014-03-26

Clementia Pharmacueticals Inc. Appoints Francois Nader, M.D. to Board of Directors

2014-03-25

Singulex, in Partnership with Tecan, Commences Commercial Development of Ultrasensitive Sgx ClarityTM System for in vitro Diagnostics Market - See more at: http://www.singulex.com/singulex-press-releases/#sthash.CObq5IF4.dpuf

2014-03-25

Roka Bioscience Atlas® Listeria monocytogenes LmG2 Detection Assay Expands Food Safety Testing Offering with Complete Solution for Listeria

2014-03-25

Anders Malm appointed Managing Director at Ecron Acunova GmbH, Germany

2014-03-24

Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes

2014-03-24

Sonendo® Closes $10 Million Venture Debt Facility with Oxford Finance

2014-03-24

Sonendo® Closes $10 Million Venture Debt Facility with Oxford Finance

2014-03-24

Good Start Genetics Presents New Data Further Validating Clinical Value of GoodStart Select(tm) at PCRS Annual Meeting

2014-03-22

Medigus Receives Fda Clearance For Next Generation Muse™ System

2014-03-20

Otonomy Appoints Vickie Capps to Board of Directors

2014-03-20

Medigus Announces Study Validating Muse’S Safety And Efficacy In Gerd Patients To Be Presented At Sages 2014

2014-03-20

William R. Ringo Joins Mirati Board of Directors

2014-03-19

Singulex’s Proprietary Ultrasensitive Research Test for Cardiac Troponin-I Predicts Coronary Heart Disease in the General

2014-03-18

Igenica Biotherapeutics Enrolls First Patient in Phase 1 Study of IGN523 in Acute Myeloid Leukemia

2014-03-17

Acceleron and Celgene Announce Interim Clinical Data for Sotatercept in Patients with End Stage Renal Disease on Hemodialysis at the 2014 National Kidney Foundation Spring Clinical Meeting

2014-03-17

Relypsa Announces Fourth Quarter and Full Year 2013 Financial Results

2014-03-17

Mirati Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

2014-03-17

BioLineRx Reports Year End 2013 Financial Results

2014-03-17

Good Start Genetics Announces Collaboration with PerkinElmer to Bring GoodStart Select ™ Carrier Screening Tests to Broader Women’s Health Market

2014-03-16

Intercept Announces Positive Pivotal Phase 3 POISE Trial Results

2014-03-14

Intercept Pharmaceuticals Announces 2013 Financial Results

2014-03-14

BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 in Immunotherapy

2014-03-14

Durata Therapeutics, Inc. Reports Fourth Quarter and Full-Year 2013 Financial Results

2014-03-13

Response Biomedical Corp. Announces Fourth Quarter and Fiscal 2013 Financial Results

2014-03-13

Cleave is featured in Nature Biotechnology's academic spinouts of 2013

2014-03-12

Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update

2014-03-11

Practice Fusion Updates Logo to Mark Next Phase in its Evolution

2014-03-11

Cerapedics Announces Positive Results From IDE Clinical Trial

2014-03-10

Alector Teams Up with Johnson & Johnson Innovation to Explore Novel Alzheimer’s Target

2014-03-07

RedHill Biopharma Provides Update on RHB-102 Development and Intellectual Property

2014-03-05

Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product

2014-03-04

Audentes Therapeutics Announces Significant Additions to Leadership Team

2014-03-03

BioLineRx Announces Underwritten Public Offering of its American Depositary Shares

2014-03-03

RedHill Biopharma and IntelGenx Submit Response to FDA CRL for RHB-103 Migraine Oral-Film

2014-02-28

Roka Bioscience Awarded AOAC-RI Certification For Atlas® STEC Eg2 Combo Detection Assay

2014-02-27

RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation

2014-02-27

NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results

2014-02-27

Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations

2014-02-26

Acceleron Pharma Reports Fourth Quarter and Year Ended 2013 Financial Results

2014-02-26

InspireMD Reports Financial Results for the Quarter and Six Month Period Ended December 31, 2013

2014-02-25

Otonomy Appoints Robert Savel as Chief Technical Officer

2014-02-25

Cardioxyl Pharmaceuticals Initiates First Clinical Trial of CXL-1427

2014-02-25

RedHill Biopharma Reports 2013 Fourth Quarter and Year-End Financial Results

2014-02-24

PointClickCare and TigerText Bring Integrated Secure Text Messaging to Electronic Health Records

2014-02-24

BioLineRx Appoints Dr. Sandra Panem to Board of Directors

2014-02-21

Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules

2014-02-19

Ornim Medical completes $10 million fundraising from OrbiMed Israel, with participation by GE and existing investors

2014-02-18

Intercept Expands Its Board of Directors With Appointments of Sanj K. Patel and Glenn Sblendorio

2014-02-13

Principia Biopharma Expands Executive Management Team

2014-02-12

BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia

2014-02-12

Ornim Medical Announces New Study Results Demonstrating the Value of the CerOx™ Cerebral Oxidation Monitor in the Treatment of Patients with Severe Traumatic Brain Injury

2014-02-11

Response Biomedical Corp. secures US$2.5 Million Term Loan

2014-02-10

Pieris Achieves Preclinical Milestone Payment in Sanofi Collaboration

2014-02-06

NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference

2014-02-06

Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results

2014-02-05

Audentes Therapeutics and Genethon Announce Agreement to Develop Treatment for Severe Genetic Disease X-Linked Myotubular Myopathy

2014-02-05

TigerText Hires Former Symantec and LinkedIn Leaders to Build Out Engineering and Product Teams

2014-02-05

Report: Practice Fusion Nabs Top Spot as the Largest Cloud-Based EHR in the U.S.

2014-02-05

ViewRay Announces World's First Patients Treated Using MRI-Guided Radiation Therapy

2014-02-05

InspireMD Reports Successful Implantation of the New CGuardTM Carotid Embolic System with MicroNetTM Technology

2014-02-04

RedHill Biopharma and IntelGenx Receive Complete Response Letter from FDA for RHB-103 Oral Film for Acute Migraines

2014-02-04

Roka Bioscience Awarded AOAC-RI Certification For Atlas® E. coli O157:H7 EG2 Detection Assay

2014-02-04

Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales

2014-02-04

Relypsa Completes Enrollment of Phase 1 Onset-of-Action Study for Patiromer

2014-01-29

Clementia Pharmaceuticals Inc. Announces Key Leadership Appointments

2014-01-28

Acceleron Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

2014-01-28

Igenica Raises $14 Million in Additional Series C Funding to Advance Product Pipeline and Technology Platform

2014-01-27

Ambit Biosciences Appoints Mark Foletta To Board Of Directors

2014-01-27

TigerText Caps Record Year with $21 Million Series B Investment to Accelerate Market Penetration

2014-01-24

Medigus Unveils Commercial Strategy and New Branding for the MUSE™ System

2014-01-23

BioLineRx Receives Orphan Drug Designation for Novel Stem Cell Mobilization Treatment

2014-01-22

RedHill Biopharma Closes Previously Announced $11.7 Million Private Placement

2014-01-21

Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request

2014-01-13

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment

2014-01-13

arGEN-X receives two preclinical milestone payments under collaboration with Shire

2014-01-13

arGEN-X starts Phase Ib expansion cohorts with ARGX-110, a novel anti-CD70 antibody, in cancer patients

2014-01-13

Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics

2014-01-13

Relypsa Provides Corporate Update

2014-01-09

Adimab Announces New Partnerships with Jounce, Five Prime, and Alector

2014-01-09

RedHill Biopharma Announces Closing of $8.5 Million Private Placements from OrbiMed and Broadfin

2014-01-09

CLEMENTIA PHARMACEUTICALS INC. ANNOUNCES CLOSING OF $22.5 MILLION SERIES A FINANCING WITH PREEMINENT U.S. AND CANADIAN HEALTHCARE VENTURE CAPITAL FUNDS

2014-01-09

Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology

2014-01-08

BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment

2014-01-06

Eddingpharm Acquired Global Rights to Oncology Assets, Including Telatinib, from ACT Biotech

2014-01-02

Cerenis Reports Top-Line Phase II Results for its HDL Mimetic CER-001

February 2, 2016

Watch OrbiMed Advisors' Managing Partner, Sam Isaly on CNBC US.

我们始终看重专业素养高于商业利害。奥博资本崇尚合作互利, 25年来我们始终以团队协作为核心,竭诚合作,优势互补。